Ann: Optiscan Reveals InVue Imaging Device for Precision Surgery, page-2

Dr Farah adds:“The potential benefits flowing from the InVue™ cannot be over-estimated. Diagnostic pathology is such a critical component in the surgical treatment of cancer, and for so long it has been disconnected from this process. InVue™ brings pathology and surgery together in the operating theatre to enhance the capabilities of both, and ultimately facilitate faster and more accurate patient care.”

Another positive development from Optiscan with it`s own digital diagnostic surgical offering.
This should allow the breast cancer study to progress at Royal Melbourne Hospital.

https://thewest.com.au/business/bulls-n-bears/optiscan-on-cusp-of-real-time-cancer-imaging-breakthrough-c-11951222

Add the recently announced Robotic development collaboration with Mayo and the $3m funding for development of miniaturized application for Gastro
and the future looks bright especially in light of the proven quality of Optiscan`s technology.